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Background: Diagnosis of psoriatic arthritis (PsA), in a period of 12 months from the onset of the first articular
episode, permits of identifying the early form defined as “early PsA”. The recognition of the disease in this phase
leads to better outcome.
The aim of this study was to identify peculiar clinical and/or laboratory findings that could be useful for the
diagnosis of “early PsA”.
Findings: Thirty-five patients with early onset of arthritis were observed. The following data were collected for each
patient: family and personal history, physical examination, tender and swollen joint counts (TJC, SJC), tender
entheseal count, presence of dactylitis and low back pain (LBP), and laboratory tests.
Among the 35 total patients, 24 showed skin and/or nail psoriasis or a family history of psoriasis.
The remaining 11 patients showed absence of concomitant or previous psoriasis and/or familiarity for psoriasis. The
comparison between the two groups showed that patients with psoriasis had a significant presence of LBP,
dactylitis and enthesitis than patients with psoriasis.
Conclusions: The study confirms that the distinctive clinical findings of PsA is psoriasis, but also LBP, dactylitis and
enthesitis have a relevant role in early identification. A low number of SJC and TJC are frequently observed in early
phases of PsA than in other forms of early arthritis. These aspects could be mostly helpful when psoriasis is not
detected or can follow arthritis in absence of familiar positivity, making difficult PsA diagnosis.
In conclusion, careful medical history, clinical examination and first-level laboratory investigations are useful to
characterize early phases of PsA.
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Psoriatic arthritis (PsA) is a chronic inflammatory
arthropathy, belonging to the spondyloarthritic area,
usually associated with skin and/or nail psoriasis or with
its familiarity (Moll & Wright 1973). Other clinical sites
such as the bowel, eye and cardiovascular system be
variably involved (Scarpa et al. 2000; Niccoli et al. 2012;
Shang et al. 2012; Costa et al. 2012).
The progress in the knowledge of new imaging tech-
niques has changed the diagnostic approach to this con-
dition (Soscia et al. 2012; Tan et al. 2014; Poggenborg
et al. 2014; Gladman 2012), even if final diagnosis mainly* Correspondence: rscarpa@unina.it
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in any medium, provided the original work is prelies on clinical evaluation performed by a rheumatolo-
gist. It usually refers to a characteristic presentation of
joints, spine and enthesis inflammatory findings, a nega-
tive rheumatoid factor in presence of psoriasis or its
familiarity (Duarte et al. 2012).
Diagnosis of PsA, in a period of 12 months from the
onset of the first articular episode, permits of identifying
the early form defined as “early PsA”. The recognition of
the disease in this phase leads to better outcome. How-
ever, in the context of clinical practice, in early phases it
is complex to rule out other inflammatory diseases, such
as rheumatoid arthritis, undifferentiated arthritis and
other spondyloarthritides (Gladman 2012).
In 2006, a set of classification criteria was developed
by the CASPAR (ClASsification criteria for Psoriatic
ARthritis) Study Group, with the aim of identifyingOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Clinical and laboratory findings of early arthritis








TJC 6.0 (0–28) 13.45 (8–24) <0.05
SJC 0.9 (0–5.0) 2.54 (0–10) <0.05
LBP, n (%) 16; 66.6% 0 <0.001
Dactylitis, n (%) 11; 45,8% 0 <0.001
Enthesitis, n (%) 5; 20.8% 0 <0.01
ESR > 15 mm/1 h, n (%) 6; 25% 11; 100% ns
CRP > 0.5 mg/dL, n (%) 6; 25% 11; 100% ns
RF positivity, n (%) 0 9; 81.8% 0.01
Anti-CCP positivity, n (%) 0 4; 36.3% ns
Uveitis, n (%) 3; 12.5% 0 ns
Data expressed as mean ± range, unless otherwise indicated.
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in clinical research context (Duarte et al. 2012). Al-
though CASPAR Criteria do not represent diagnostic
criteria, these have had a wide consensus, due to high
specificity (98.7%) and good sensitivity (91.4%), con-
firmed also retrospectively (Taylor et al. 2006; Tillett
et al. 2012). Furthermore, CASPAR criteria have been
applied in some studies on early PsA showing good sen-
sitivity (88.7%) and high specificity (99.1%), but data are
still few (van den Berg et al. 2012; D'Angelo et al. 2009).
While a distinctive clinical finding of PsA is psoriasis,
dactylitis, enthesitis and inflammatory low-back pain
should be present without a pathognomonic role. In
Addition, no laboratory findings can be helpful in ad-
dressing PsA diagnosis. The aim of this study was to
identify peculiar clinical and/or laboratory findings that
could be useful for the diagnosis of “early PsA”.
Patients and methods
In 7-month period, 35 patients (M/W: 7/28; mean age:
47.0 years, range: 17–78 years) with early onset of arth-
ritis (within 12 weeks of onset), attending Rheumatology
Unit of University Federico II of Naples, were observed.
The average onset of arthritis was 5.6 months (range 2–
12 months). The following data were collected for each
patient: family and personal history, including familiar
and/or previous psoriasis, physical examination, tender
and swollen joint counts (TJC, SJC), tender entheseal
count, presence of dactylitis and low back pain. Eva-
luation of rheumatoid factor (RF), anti-cyclic citrulli-
nated peptide antibodies (anti-CCP) and inflammatory
indices, including erythrocyte sedimentation rate (ESR)
and C-reactive protein (CRP), were performed.
Written informed consent was obtained from the pa-
tient for the publication of this report.
Statistical analysis was performed using the SPSS soft-
ware, version 18 (SPSS inc, Chicago, Ill). All variables were
normally distributed. Analysis of variance (ANOVA) was
used to assess differences between group means.
Results
Among the 35 total patients, twenty-four showed skin
and/or nail psoriasis or a family history of psoriasis (M/W:
5/19, mean age 44.9 years, range 17–73 years; mean du-
ration of articular disease 5.8 months, range 2–12). The
remaining eleven patients showed absence of concomitant
or previous psoriasis and/or familiarity for psoriasis
(M/W: 2/9, mean age 51.5 years, range 28–78 years; mean
disease duration 5.0 months, range 2–12).
The comparison between the two groups (Table 1)
showed that patients with psoriasis had a significant pre-
sence of inflammatory back pain, dactylitis and enthesitis
(respectively p <0.001, p <0.001 and p <0.01), whereas pa-
tients without psoriasis showed a greater TJC (p <0.001)SJC (p <0.001), and RF positivity (p <0.01) than patients
with psoriasis. In the group of patients with psoriasis, the
application of CASPAR criteria led to a PsA diagnosis in
all the patients, while none of the patients in the group
without psoriasis was satisfying these criteria.
Conclusions
For a long time, PsA has been considered a low grade
inflammatory condition and only most recently increa-
sing data have provided evidence on the severe impact
of this disease, establishing at same time the importance
of an early diagnosis and treatment (Gladman 2012;
Scarpa et al. 2011).
The CASPAR criteria consist of established inflamma-
tory articular disease with at least a sum of three points
from the following: current psoriasis (2 points), a history
of psoriasis (1 point), a family history of psoriasis (unless
current psoriasis was present or there was a history of
psoriasis; 1 point), dactylitis (1 point), juxta-articular
new bone formation (1 point), RF negativity (1 point),
and nail dystrophy (1 point) (Taylor et al. 2006).
In this study, co-occurrence of inflammatory back pain
and dactylitis were present respectively in above 46%
and 66% of patients with psoriasis and were very helpful
in addressing early PsA diagnosis. Enthesitis was de-
tected in above 21% of patients with psoriasis.
Patients with psoriasis showed a lower number of TJC
and SJC, than patients without psoriasis; previous epi-
sode of uveitis was referred in three of 24 patients with
psoriasis and in no one of patients without psoriasis.
With regard to laboratory findings, all the patients
without psoriasis showed increased ESR and C-RP, RF
and anti-CCP positivity was found in above 82% and
36% of them. Differently, only 25% of patients with pso-
riasis showed increase of ESR and CRP and no one RF
and anti-CCP positivity.
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dings of PsA is psoriasis, but also inflammatory low-
back pain, dactylitis and enthesitis have a relevant role
in early identification. A low number of SJC and TJC, as
well anti-CCP and RF negativity and no increase of ESR
and C-RP are most frequently observed in early phases
of PsA than in other forms of early arthritis. These
aspects could be mostly helpful when psoriasis is not
detected or can follow arthritis in absence of familiar
positivity, making difficult PsA diagnosis.
The study shows several limitations: mainly the number
of patients which is low and for this reason the results
need to be supported by studies on larger populations.
Although the progress in the knowledge of new im-
aging techniques has changed the diagnostic approach
to PsA (Soscia et al. 2012; Tan et al. 2014; Poggenborg
et al. 2014; Gladman 2012), but PsA diagnosis still relies
mainly on clinical evaluation.
Therefore, the results of the present observation may
be interesting from practical point of view. The key mes-
sage is that careful medical history, clinical examination
and first-level laboratory investigations such as ESR,
CRP, anti-CCP and FR are reasonably useful to cha-
racterize early phases of PsA. Delay in PsA diagnosis
significantly contributes to poor outcome of the patient,
so early identification of simple and helpful indicators
could allow for the characterization of “early PsA”.
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